Literature DB >> 27834728

Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.

Nora Mirza1,2, Manfred Zierhut3, Andreas Korn4, Antje Bornemann5, Wichard Vogel1, Barbara Schmid-Horch6, Wolfgang A Bethge1, Stefan Stevanović2, Helmut R Salih1,7, Lothar Kanz1, Hans-Georg Rammensee2, Sebastian P Haen8,2.   

Abstract

Graft-versus-host disease (GVHD) represents the major nonrelapse complication of allogeneic hematopoietic cell transplantation. Although rare, the CNS and the eye can be affected. In this study, manifestation in the retina as part of the CNS and T-cell epitopes recognized by the allogeneic T cells were evaluated. In 2 of 6 patients with posttransplantation retina diseases and 6 of 22 patients without ocular symptoms, antigen-specific T-cell responses against retina-specific epitopes were observed. No genetic differences between donor and recipient could be identified indicating T-cell activation against self-antigens (graft versus self). Transplantation of a preexisting immunity and cross-reactivity with ubiquitous epitopes was excluded in family donors and healthy individuals. In summary, an immunological reaction against retina cells represents a mechanism of graft-versus-host interaction following hematopoietic cell transplantation.

Entities:  

Keywords:  T-cell epitope; allogeneic hematopoietic cell transplantation; autoimmunity; graft-versus-host disease; retina

Mesh:

Substances:

Year:  2016        PMID: 27834728      PMCID: PMC5137740          DOI: 10.1073/pnas.1609118113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Autoimmune thrombocytopenia following tandem autologous peripheral blood stem cell transplantation for refractory germ cell tumor.

Authors:  I Ahmad; K Haider; R Kanthan
Journal:  Bone Marrow Transplant       Date:  2004-08       Impact factor: 5.483

2.  Correlation Between Structural and Functional Retinal Changes in Parkinson Disease.

Authors:  Manpreet Kaur; Rohit Saxena; Digvijay Singh; Madhuri Behari; Pradeep Sharma; Vimla Menon
Journal:  J Neuroophthalmol       Date:  2015-09       Impact factor: 3.042

3.  A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa.

Authors:  Anneke I den Hollander; Terri L McGee; Carmela Ziviello; Sandro Banfi; Thaddeus P Dryja; Federico Gonzalez-Fernandez; Debashis Ghosh; Eliot L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

Review 4.  The repertoire of human tumor-associated epitopes--identification and selection of antigens and their application in clinical trials.

Authors:  Sebastian P Haen; Hans-Georg Rammensee
Journal:  Curr Opin Immunol       Date:  2013-04-23       Impact factor: 7.486

5.  Optimizing peptide matrices for identifying T-cell antigens.

Authors:  Melissa L Precopio; Tiffany R Butterfield; Joseph P Casazza; Susan J Little; Douglas D Richman; Richard A Koup; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

6.  CNS angiitis in graft vs host disease.

Authors:  M Ma; G Barnes; J Pulliam; D Jezek; R J Baumann; J R Berger
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

7.  Mutation analysis identifies GUCY2D as the major gene responsible for autosomal dominant progressive cone degeneration.

Authors:  Veronique B D Kitiratschky; Robert Wilke; Agnes B Renner; Ulrich Kellner; Maria Vadalà; David G Birch; Bernd Wissinger; Eberhart Zrenner; Susanne Kohl
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

8.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

Authors:  K R Cooke; G R Hill; J M Crawford; D Bungard; Y S Brinson; J Delmonte; J L Ferrara
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

9.  High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.

Authors:  M J Pittet; D Valmori; P R Dunbar; D E Speiser; D Liénard; F Lejeune; K Fleischhauer; V Cerundolo; J C Cerottini; P Romero
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

10.  Novel GUCA1A mutations suggesting possible mechanisms of pathogenesis in cone, cone-rod, and macular dystrophy patients.

Authors:  Kunka Kamenarova; Marta Corton; Blanca García-Sandoval; Patricia Fernández-San Jose; Valentin Panchev; Almudena Avila-Fernández; Maria Isabel López-Molina; Christina Chakarova; Carmen Ayuso; Shomi S Bhattacharya
Journal:  Biomed Res Int       Date:  2013-08-14       Impact factor: 3.411

View more
  7 in total

1.  Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

Authors:  Sebastian P Haen; Vicky Eyb; Nora Mirza; Aline Naumann; Andreas Peter; Markus W Löffler; Christoph Faul; Wichard Vogel; Wolfgang A Bethge; Hans-Georg Rammensee; Lothar Kanz; Martin Heni
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-16       Impact factor: 4.553

2.  Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

Authors:  Markus W Löffler; Daniel J Kowalewski; Linus Backert; Jörg Bernhardt; Patrick Adam; Heiko Schuster; Florian Dengler; Daniel Backes; Hans-Georg Kopp; Stefan Beckert; Silvia Wagner; Ingmar Königsrainer; Oliver Kohlbacher; Lothar Kanz; Alfred Königsrainer; Hans-Georg Rammensee; Stefan Stevanović; Sebastian P Haen
Journal:  Cancer Res       Date:  2018-05-22       Impact factor: 12.701

Review 3.  Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire.

Authors:  Sebastian P Haen; Markus W Löffler; Hans-Georg Rammensee; Peter Brossart
Journal:  Nat Rev Clin Oncol       Date:  2020-06-22       Impact factor: 66.675

4.  Manifestation of Clinical Categories of Ocular Graft-versus-Host Disease.

Authors:  Yuan Qiu; Jing Hong; Rongmei Peng
Journal:  J Ophthalmol       Date:  2018-08-08       Impact factor: 1.909

5.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10

Review 6.  T-Cell Metabolism in Hematopoietic Cell Transplantation.

Authors:  Hung D Nguyen; Sandeepkumar Kuril; David Bastian; Xue-Zhong Yu
Journal:  Front Immunol       Date:  2018-02-09       Impact factor: 7.561

7.  Regulatory T Cells and Ocular Graft Versus Host Disease: A Novel Treatment Approach.

Authors:  Mohammad Reza Pishnamaz; Ebrahim Jafarzadehpour; Razieh Pishnamaz
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.